EPW
LLY icon

Evolve Private Wealth’s Eli Lilly LLY Stock Holding History

Evolve Private Wealth’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.89M Sell
5,743
-2,165
-27% -$2.21M 0.42% 37
2026
Q1 		$7.27M Buy
7,908
+2,444
+45% +$2.48M 0.39% 37
2025
Q4 		$5.87M Buy
+5,464
New +$5.22M 0.35% 48

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Evolve Private Wealth's LLY Position: Q2 2026 in Review

Evolve Private Wealth reduced its Eli Lilly (LLY) stake by 27% in Q2 2026, selling an estimated $2.21M and leaving 5,743 shares worth $6.89M. The position accounts for 0.42% of the portfolio, ranked #37.

Evolve Private Wealth first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. The position peaked at $7.27M in Q1 2026. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Evolve Private Wealth held 5,743 shares of Eli Lilly worth $6.89M as of Q2 2026.
  • Evolve Private Wealth sold 2,165 Eli Lilly shares in Q2 2026, an estimated $2.21M.
  • Eli Lilly made up 0.42% of Evolve Private Wealth's portfolio in Q2 2026, its #37 holding.
  • Evolve Private Wealth first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • Evolve Private Wealth's Eli Lilly position peaked at $7.27M in Q1 2026.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Evolve Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.